Scottish-based cleantech business Penrhos Bio has raised £3 million in Series A funding supported by Innova Partnerships.

Novarum DX, the mobile software arm of BBI Solutions, has been bought out by a small group of investors led by Innova Partnerships and the existing management. The deal should let the company build on its lateral flow test customer base and extend into adjacent markets.

Biotangents launched the AmpliSpec LAB Mastitis device in an event at the Moredun Research Institute, close to its headquarters at the Pentlands Science Park near Edinburgh. The disease is estimated to cost the global dairy industry around £25 billion a year.

AmpliSpec™ LAB BVDV is Biotangents’ first next generation molecular diagnostic assay for the detection of BVDV in cattle. Its unique design combines LAMP technology, lyophilised bead technology and Biotangents’...

Cellexus have partnered with Castleford-based Verder Liquids to provide pumps to be used for the acid / base pump, included as standard with the CellMaker Plus and Low Flow bioreactor systems.

First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany.

Dxcover Limited today announced it has raised $11.9 (£9.7) million in Series A and grant financing. The funding will support the ongoing development of the Dxcover® Liquid Biopsy Platform for the detection...

Antibody Analytics is excited to announce a strategic partnership with HistologiX, a company specialising in cellular and digital pathology services. As precision medicine is embraced and the number of targeted...

HITRUST Implemented, 1-year Certification validates Relaymed is committed to managing cybersecurity risk and protecting sensitive information Orlando, FL – Relaymed,…

Established as a social enterprise, dedicated to securing and prioritising the provision of diagnostic products and components for developing countries to ensure that local manufacturing initiatives can operate...

Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology, and is joined as an investment partner by Eos Advisory.

Dxcover Limited, a diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the launch of the Dxcover® Infrared Platform, a ground-breaking...

A medical spin-out from the University of Strathclyde is preparing for expansion after signing a lease on new office and laboratory facilities.

We are very pleased that Dr Yvonne Davies and Professor Richard Hammond have joined Penrhos Bio full time. Yvonne is Head of Business development and Richard is CEO.

Fiona Bellot joins the firm as its sales director, bringing with her a “wealth of experience” across the life sciences industry from previous appointments with Proteintech Group and RoslinCT, among others.

Unilever and Innova Partnerships have launched a joint venture biotechnology company, Penrhos Bio, to commercialise a technology that means self-cleaning surfaces could become a reality.